Published in Free Radic Biol Med on January 01, 1996
Cancer is a preventable disease that requires major lifestyle changes. Pharm Res (2008) 3.28
Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. J Virol (2005) 1.39
Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1. Biochem J (2004) 1.36
Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview. J Transl Med (2011) 1.33
Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy. J Transl Med (2006) 1.10
Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency. Dig Dis Sci (2002) 1.06
Aldehydes potentiate alpha(2)(I) collagen gene activity by JNK in hepatic stellate cells. Free Radic Biol Med (2001) 1.04
RNA Viruses: ROS-Mediated Cell Death. Int J Cell Biol (2014) 1.01
Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress. Int J Cancer (2008) 0.99
Steatosis and insulin resistance in hepatitis C: a way out for the virus? World J Gastroenterol (2009) 0.96
Oxidative stress in hepatitis C infected end-stage renal disease subjects. BMC Infect Dis (2006) 0.92
Increased oxidative stress, decreased total antioxidant capacity, and iron overload in untreated patients with chronic hepatitis C. Dig Dis Sci (2009) 0.90
p21WAF1/CTP1 expression and hepatitis virus type. Dig Dis Sci (2001) 0.90
Arsenic trioxide inhibits hepatitis C virus RNA replication through modulation of the glutathione redox system and oxidative stress. J Virol (2008) 0.89
The use of selected nutrition supplements and complementary and alternative medicine in liver disease. Nutr Clin Pract (2006) 0.89
Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C. World J Gastroenterol (2010) 0.88
Relationship of Oxidative Stress with HIV Disease Progression in HIV/HCV Co-infected and HIV Mono-infected Adults in Miami. Int J Biosci Biochem Bioinforma (2012) 0.87
Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami. HIV Med (2011) 0.87
Increased hepatic oxidative DNA damage in patients with hepatocellular carcinoma. Dig Dis Sci (2001) 0.86
Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice. Environ Health Perspect (1998) 0.85
Hepatitis C virus-induced mitochondrial dysfunctions. Viruses (2013) 0.84
The role of liver biopsy in detection of hepatic oxidative stress. Vet Med Int (2011) 0.80
The influence of treatment with pegylated interferon-alfa and ribavirin on neutrophil function and death in patients with HIV/HCV coinfection. Viral Immunol (2012) 0.80
Clastogenic factors as potential biomarkers of increased superoxide production. Biomark Insights (2007) 0.79
Establishment of chronic hepatitis C virus infection: translational evasion of oxidative defence. World J Gastroenterol (2014) 0.79
Viusid, a nutritional supplement, increases survival and reduces disease progression in HCV-related decompensated cirrhosis: a randomised and controlled trial. BMJ Open (2011) 0.79
Adiponectin serum level in chronic hepatitis C infection and therapeutic profile. World J Hepatol (2015) 0.78
8-Hydroxy-2'-deoxyguanosine expression predicts hepatocellular carcinoma outcome. Oncol Lett (2011) 0.78
Hepatic HMOX1 expression positively correlates with Bach-1 and miR-122 in patients with HCV mono and HIV/HCV coinfection. PLoS One (2014) 0.78
Interleukin-17A Plays a Pivotal Role in Chemically Induced Hepatocellular Carcinoma in Mice. Dig Dis Sci (2016) 0.78
Cytogenetic methods for detection of oxidative stress and evaluation of antioxidant therapy in hepatitis C infection. Hepat Mon (2011) 0.76
Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C. J Gastroenterol (2007) 0.76
Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease. BMC Med (2016) 0.75
Regulation of the CYP1A1 gene by 2,3,7,8-tetrachlorodibenzo-p-dioxin but not by beta-naphthoflavone or 3-methylcholanthrene is altered in hepatitis C virus replicon-expressing cells. Mol Pharmacol (2006) 0.75
Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis. Oncotarget (2016) 0.75
Effect of tea polyphenol on oxidative injury in S180 cells induced hepatocarcinoma mice. Int J Mol Sci (2012) 0.75
The Paradoxical Effects of Different Hepatitis C Viral Loads on Host DNA Damage and Repair Abilities. PLoS One (2017) 0.75
Evolution of liver transplantation. Hepatology (1982) 19.54
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci U S A (1991) 3.85
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16
Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. Gastroenterology (1994) 3.15
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
Liver transplantation in adults. Hepatology (1982) 2.89
Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62
Hypothalamic-pituitary-gonadal dysfunction in men using cimetidine. N Engl J Med (1979) 2.61
Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med (2000) 2.52
A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci U S A (1994) 2.39
The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg (1994) 2.32
Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med (1993) 2.29
The hepatotropic influence of cyclosporine. Surgery (1990) 2.27
Effect of bile on cyclosporin absorption in liver transplant patients. Br J Clin Pharmacol (1988) 2.21
Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc Natl Acad Sci U S A (1990) 2.18
Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci (1996) 2.15
Acute liver failure. Lancet (1995) 2.09
Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet (1986) 2.07
Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology (1981) 2.07
The use of interferon for the treatment of viral hepatitis in pediatric liver transplant recipients. J Okla State Med Assoc (1995) 2.02
Biliary Excretion of Cyclosporine in Liver Transplant Patients. Transplant Proc (1985) 1.98
Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. Proc Natl Acad Sci U S A (1991) 1.96
Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94
Liver transplantation: an overview. Hepatology (1988) 1.86
Gastrointestinal manifestations of Behcet's disease. J Clin Gastroenterol (2000) 1.81
Monitoring and treatment of intestinal allograft rejection in humans. Transplant Proc (1993) 1.78
Heatstroke: its clinical and pathological presentation, with particular attention to the liver. Am J Gastroenterol (1992) 1.76
Induction of DR/IA antigens in human liver allografts. An immunocytochemical and clinicopathologic analysis of twenty failed grafts. Transplantation (1985) 1.75
Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis (2007) 1.73
In vivo hepatic volume determination using sonography and computed tomography. Validation and a comparison of the two techniques. Gastroenterology (1985) 1.71
Gastroenterological oncology: a top priority. Dig Liver Dis (2000) 1.70
Histological features after liver transplantation in alcoholic cirrhotics. J Hepatol (2001) 1.69
Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching. Ital J Gastroenterol Hepatol (1997) 1.63
Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2. Gastroenterology (1990) 1.63
Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci (1998) 1.63
Huperzine A for Alzheimer's disease. Cochrane Database Syst Rev (2008) 1.62
Blood ethanol levels in sober alcohol users seen in an emergency room. Life Sci (1981) 1.58
Liver transplantation for fulminant hepatic failure. Semin Liver Dis (1985) 1.56
Use of external shock-wave lithotripsy and adjuvant ursodiol for treatment of radiolucent gallstones. A national multicenter study. Dig Dis Sci (1989) 1.56
Transjugular renal biopsy in patients with liver disease. Am J Kidney Dis (2001) 1.56
Angiography of liver transplantation patients. Radiology (1985) 1.53
Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology (1987) 1.53
Acute and chronic renal failure in liver transplantation. Nephron (1990) 1.52
Morphological monitoring of human small bowel allografts. Transplant Proc (1993) 1.52
Medical aspects of liver transplantation. Hepatology (1984) 1.52
Sex hormone-related functions in regenerating male rat liver. Gastroenterology (1986) 1.51
Digestive neuroendocrine tumours: diagnosis and treatment in Italy. A survey by the Oncology Study Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis (2001) 1.50
p38 kinase is activated in the Alzheimer's disease brain. J Neurochem (1999) 1.50
Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis. Hepatology (1992) 1.50
Estrogen and androgen receptors in liver: their role in liver disease and regeneration. Semin Liver Dis (1985) 1.50
Estrogen-binding proteins of male rat liver: influences of hormonal changes. Arch Biochem Biophys (1980) 1.48
Autoimmune gastritis: histology phenotype and OLGA staging. Aliment Pharmacol Ther (2012) 1.48
The presence of two distinct 8-oxoguanine repair enzymes in human cells: their potential complementary roles in preventing mutation. Nucleic Acids Res (1998) 1.46
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation (1992) 1.45
Gastrointestinal tract hemorrhage. The value of a nasogastric aspirate. Arch Intern Med (1990) 1.44
Extraction and partial purification of a hepatic stimulatory substance in rats, mice, and dogs. Cancer Res (1987) 1.43
Gonadal dysfunction and inadequate sexual performance in alcoholic cirrhotic men. Gastroenterology (1988) 1.43
Hypogonadism in alcoholic liver disease: evidence for a double defect. Gastroenterology (1974) 1.43
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer (1999) 1.43
Ageing affects anoxia/reoxygenation injury in rat hepatocytes. Scand J Gastroenterol (1998) 1.42
Treatment of chronic hepatitis B and hepatitis C with interferon alfa-2b. Am Fam Physician (1996) 1.41
Upper gastrointestinal injury caused by diquat. Gastrointest Endosc (1992) 1.41
Mesenchymal tumors of the liver. Clin Liver Dis (2001) 1.40
Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology (1998) 1.39
Oxygen free radical involvement in ischemia and reperfusion injury to brain. Neurosci Lett (1988) 1.38
Hormonal treatment of hepatocellular carcinoma. J Hepatol (1991) 1.38
The long term outcome of gastric non-invasive neoplasia. Gut (2003) 1.37
Formation of 8-hydroxydeoxyguanosine, hydroxyl free radical adduct of DNA in granulocytes exposed to the tumor promoter, tetradecanoylphorbolacetate. Biochem Biophys Res Commun (1986) 1.36
The impact of previous HBV infection on the course of chronic hepatitis C. Am J Gastroenterol (2000) 1.36
Methylene blue plus light mediates 8-hydroxy 2'-deoxyguanosine formation in DNA preferentially over strand breakage. Nucleic Acids Res (1990) 1.35
Heartburn of pregnancy. Gastroenterology (1977) 1.32
Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma. J Pediatr (1985) 1.32
Sensitivity of activated human lymphocytes to cyclosporine and its metabolites. Hum Immunol (1988) 1.31
Influence of calcium on sodium and potassium absorption by fresh and aged bean stem slices. Plant Physiol (1970) 1.31
Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology (1986) 1.31
Diagnostic and interventional radiology in liver transplantation. Gastroenterol Clin North Am (1988) 1.31
Effect of pregnancy on gastrointestinal transit. Dig Dis Sci (1982) 1.29
Low temperature photo-induced reactions in green leaves and chloroplasts. Biochim Biophys Acta (1971) 1.27
Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases. Hepatology (1986) 1.27
Analysis of liver transplantation. Hepatology (1984) 1.26
Role of bile and bile salts on cyclosporine absorption in dogs. Transplant Proc (1987) 1.24
The quality of life following liver transplantation: a preliminary report. Gastroenterol Clin North Am (1988) 1.23
Redox regulatory mechanisms of cellular signal transduction. Arch Biochem Biophys (2000) 1.23
Nutritional status and lung function in patients with emphysema and chronic bronchitis. Chest (1983) 1.23
Effects of renal impairment on liver transplantation. Gastroenterology (1987) 1.23
Caloric restriction mimetics: metabolic interventions. J Gerontol A Biol Sci Med Sci (2001) 1.22
Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet (1993) 1.21
Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. Am J Pathol (1990) 1.21
Response to interferon alpha therapy is influenced by the iron content of the liver. J Hepatol (1994) 1.21
Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J Biochem Biophys Methods (1984) 1.20
The "pseudo-cholangiocarcinoma sign" in patients with cavernous transformation of the portal vein and its effect on the serum alkaline phosphatase and bilirubin levels. Am J Gastroenterol (1995) 1.20
Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures. Hepatology (1990) 1.20